Calpains and calpastatin in SH-SY5Y neuroblastoma cells during retinoic acid-induced differentiation and neurite outgrowth: Comparison with the human brain calpain system

Journal of Neuroscience Research

Volumn 48, Issue 3, 1997, Pages 181-191

  Grynspan, F ^a   Griffin, W B ^a   Mohan, P S ^a   Shea, T B ^c   Nixon, R A ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

calcium activated neutral proteases; calpastatin; cell differentiation

Indexed keywords

CALPAIN; CALPASTATIN; RETINOIC ACID;

ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

BRAIN; CALCIUM-BINDING PROTEINS; CALPAIN; CELL DIFFERENTIATION; CYSTEINE PROTEINASE INHIBITORS; HUMANS; ISOMERISM; MOLECULAR WEIGHT; NEURITES; NEUROBLASTOMA; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0030888520     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19970501)48:3<181::AID-JNR1>3.0.CO;2-B     Document Type: Article

References (87)

1. Adachi Y, Murachi T, Maki M, Ishii K, Hatanaka M (1990): Calpain inhibitors block TPA-dependent down-regulation of protein kinase C. Biomed Res 11:313-317.
2. Adachi Y, Takahashi AI, Takahashi C, Takano E, Murachi T, Hatanaka M (1991): Phosphorylation and subcellular distribution of calpastatin in human hematopoietic system cells. J Biol Chem 266:3968-3972.
3. Ammer H, Schultz R (1994): Retinoic acid induced differentiation of human neuroblastoma SH-SY5Y cells is associated with changes in the abundance of G proteins. J Neurochem 62:1310-1318.
4. Banik NL, Hogan EL, Jenkins MG, McDonald JK, McAlhaney WW, Sostek MB (1983): Purification of a calcium-activated neutral proteinase from bovine brain. Neurochem Res 8:1389-1405.
5. Banik NL, Chakrabarti AK, Gantt G, Hogan EL (1987a): Distribution of calcium-activated neutral proteinase activity in quacking mouse brain: a subcellular study. Brain Res 435:57-62.
6. Banik NL, Chakrabarti AK, Hogan EL (1987b): Distribution of calcium-activated neutral proteinase in myelin and cytosolic fractions in bovine white matter. Life Sci 41:1089-1095.
7. Banik NL, Chakrabarti AK, Konat GW, Gantt-Wilford G, Hogan EL (1992): Calcium-activated neutral proteinase (calpain) activity in C6 cell line: compartmentation of μ- and m-calpain. J Neurosci Res 31:708-714.
8. Biedler JL, Helson L, Spengler BA (1973): Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture: Cancer Res 33:2643-2652.
9. Billger M, Wallin M, Karlsson JO (1988): Proteolysis of tubulin and microtubule-associated proteins 1 and 2 by calpain I and II. Differences in sensitivity of assembled and disassembled microtubules. Cell Calcium 9:33-44.
10. Bradford MM (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
11. Brown BA, Nixon RA, Strocchi P, Marotta CA (1981): Characterization and comparison of neurofilament proteins from rat and mouse CNS. J Neurochem 36:143-153.
12. Croall DE (1989): Proteolytic modification of calcium-dependent protease 1 in erythrocytes treated with ionomycin and calcium. Biochemistry 28:6882-6888.
13. Croall DE, Slaughter CA, Wortham HS, Skelly CM, DeOgny L, Moomaw CR (1992): Polyclonal antisera specific for the proenzyme form of each calpain. Biochim Biophys Acta 1121:47-53.
14. Dayton WR, Schollmeyer JV, Lepley RA, Cortes LR (1981): A calcium-activated protease possibly involved in myofibrillar protein turnover. Isolation of a low-calcium-requiring form of the protease. Biochim Biophys Acta 659:48-61.
15. DeMartino GN, Croall DE (1984): Purification and characterization of a protein inhibitor of calcium-dependent proteases from rat liver. Arch Biochem Biophys 232:713-720.
16. Dosemeci A, Reese TS (1995): Effect of calpain on the composition and structure of postsynaptic densities. Synapse 20:91-97.
17. 14C]formaldehyde and sodium cyanoborohydride. Anal Biochem 87:562-565.
18. Durston AJ, Timmermans JP, Hendriks HF, de Vries NJ, Heideveld M, Nieuwkoop PD (1989): Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature 340:140-144.
19. Emori Y, Saigo K (1994): Calpain localization changes in coordination with actin-related cytoskeletal changes during early embryonic development of Drosophila. J Biol Chem 269:25137-25142.
20. Favre B, Ojha M (1991): Purification and properties of a casein kinase II-like enzyme from Neurospora crassa. FEMS Microbiol Lett 62:21-24.
21. Fischer I, Romano-Clarke G, Grynspan F (1991): Calpain-mediated proteolysis of microtubule associated proteins MAP1B and MAP2 in developing brain. Neurochem Res 16:891-898.
22. Glaser T, Kosower NS (1986a): Fusion of rat erythrocytes by membrane-motility agent A2C depends on membrane proteolysis by a cytoplasmic calpain. Eur J Biochem 159:387-392.
23. Glaser T, Kosower NS (1986b): Calpain-calpastatin and fusion. Fusibility of erythrocytes is determined by a protease-protease inhibitor [calpain-calpastatin] balance. FEBS Lett 206:115-120.
24. Goll DE, Thompson VF, Taylor RG, Zalewska T (1992): Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays 14:549-556.
25. Harris AS, Morrow JS (1988): Proteolytic processing of human brain alpha spectrin (fodrin): identification of a hypersensitive site. J Neurosci 8:2640-2651.
26. Hata A, Ohno S, Suzuki K (1992): Transcriptional activation of the gene for the large subunit of human m-calpain by 12-o-tetradecanoyl-phorbol-13-acetate. FEBS Lett 304:241-244.
27. Howard MK, Burke LC, Mailhos C, Pizzey A, Gilbert CS, Lawson D, Collins MKL, Thomas NSB, Latchman DS (1993): Cell cycle arrest of proliferating neuronal cells by serum deprivation can result in either apoptosis or differentiation. J Neurochem 60:1783-1791.
28. Imajoh S, Aoki K, Ohno S, Emori Y, Kawasaki H, Sugihara H, Suzuki K (1988): Molecular cloning of the cDNA for the large subunit of the high-Ca2+-requiring form of human Ca2+-activated neutral protease. Biochemistry 27:8122-8128.
29. Inomata M, Imahori K, Kawashima S (1986): Autolytic activation of calcium-activated neutral protease. Biochem Biophys Res Commun 138:638-643.
30. Ishiura S, Murofushi H, Suzuki K, Imahori K (1978): Studies of a calcium-activated neutral protease from chicken skeletal muscle. I. Purification and characterization. J Biochem (Tokyo) 84:225-230.
31. Ishizaki Y, Tashiro T, Kurokawa M (1983): A calcium-activated protease which preferentially degrades the 160-kDa component of the neurofilament triplet. Eur J Biochem 131:41-45.
32. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ (1993): Induction of TrkB by retinoic acid mediates biological responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron 11:321-331.
33. Karlsson JO, Blennow K, Holmberg B, Janson I, Karlsson I, Nilsson E, Wallin A, Gottfries CG (1992): Increased proteolytic activity in erythrocytes from patients with Alzheimer's disease. Dementia 3:200-204.
34. Karlsson JO, Blennow K, Janson I, Blomgren K, Karlsson I, Regland B, Wallin A, Gottfries CG (1996): Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease. Neurobiol Aging 16:901-906.
35. Kishimoto A, Kajikawa N, Tabuchi H, Shiota M, Nishizuka Y (1981): Calcium-dependent neural proteases, widespread occurrence of a species of protease active at lower concentrations of calcium. J Biochem (Tokyo) 90:889-892.
36. Kumamoto T, Kleese WC, Cong J, Goll DE, Pierce PR, Allen RE (1992): Localization of the Ca2+-dependent proteinases and their inhibitor in normal, fasted and denervated rat skeletal muscle. Anat Rec 232:60-77.
37. Laeng P, Decimo D, Pettmann B, Janet T, Labourdette G (1994): Retinoic acid regulates the development of olygodendrocyte precursor cells in vitro. J Neurosci Res 39:613-633.
38. Lane RD, Allan DM, Mellgren RL (1992): A comparison of the intracellular distribution of μ-calpain, m-calpain, and calpastatin in proliferating human A431 cells. Exp Cell Res 203:5-16.
39. Leli U, Cataldo A, Shea TB, Nixon RA, Hauser G (1992): Distinct mechanisms of differentiation of SH-SY5Y neuroblastoma cells by protein kinase C activators and inhibitors. J Neurochem 58:1191-1198.
40. Lerner RA, Green N, Alexander H, Liu FT, Sutcliffe JG, Shinnick TM (1981) Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci USA 78:3403-3407.
41. McClelland P, Lash JA, Hathaway DR (1989): Identification of major cleavage sites in the regulatory subunit of vascular calpain II. J Biol Chem 264:17428-17431.
42. Maihous C, Howard MK, Latchman DS (1994): A common pathway mediates retinoic acid and PMA-dependent programmed cell death (apoptosis) of neuronal cells. Brain Res 664:7-12.
43. Maki M, Hatanaka M, Tanako E, Murachi T (1990): Structure-function relationship of the calpastatin. In Mellgren RL, Murachi T (eds): Intracellular Calcium-Dependent Proteolysis. Boca Raton, FL: CRC Press Inc., pp 32-51.
44. Mellgren RL (1980): Canine cardiac calcium-dependent proteases: resolution of two forms with different requirements for calcium. FEBS Lett 109:129-133.
45. Mellgren RL, Repetti A, Muck TC (1982): Rabbit skeletal muscle calcium-dependent protease requiring millimolar Ca2+. Purification, subunit structure, and Ca2+-dependent autoproteolysis. J Biol Chem 257:7203-7209.
46. Mellgren RL, Lane RD, Kakar SS (1987): A sarcolemma-associated inhibitor is capable of modulating calcium-dependent proteinase activity. Biochim Biophys Acta 930:370-377.
47. Michetti M, Viotti PL, Melloni E, Pontremoli S (1991) Mechanisms of action of the calpain activator protein in rat skeletal muscle. Eur J Biochem 202:1177-1180.
48. Mohan SP, Nixon RA (1995): Purification and properties of high molecular weight calpastatin from bovine brain. J Neurochem 64:859-866.
49. Murachi T, Yoshimura N (1985): Intracellular localization of low and high calcium-requiring forms of calpain. Prog Clin Biol Res 180:165-174.
50. Mykles DL, Skinner DM (1983): Ca2+-dependent proteolytic activity in crab claw muscle. Effects of inhibitors and specificity for myofibrillar proteins. J Biol Chem 258:10474-10480.
51. Nagao S, Saido TC, Akita Y, Tsuchiya T, Suzuki K, Kawashima S (1994): Calpain-calpastatin intertactions in epidermoid carcinoma KB cells. J Biochem 115:1178-1184.
52. Nakamura M, Mori M, Morishita Y, Mori S, Kawashima S (1992): Specific increase in calcium-activated neutral protease with low calcium sensitivity (m-calpain) in proerythroblastic K562 cell line cells induced to differentiation by phorbol 12-myristate 13-acetate. Exp Cell Res 200:513-522.
53. Nixon RA, Brown BA, Marrota CA (1983): Limited proteolytic modification of a neurofilament protein involves a proteinase activated by endogenpus levels of calcium. Brain Res 275:384-388.
54. Nixon RA, Saito K-I, Grynspan F, Griffin WR, Katayama S, Honda T, Mohan PS, Shea TB, Beermann M (1994): Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann NY Acad Sci 747:77-91.
55. O'Farrell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4017-4021.
56. O'Farrell PZ, Goodman HM, O'Farrell PH (1977): High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 12:1133-1142.
57. Ohno S, Emori Y, Imajoh S, Kawasaki H, Kisaragi M, Suzuki K (1984): Evolutionary origin of a calcium-dependent protease by fusion of genes of a thiol protease and a calcium-binding protein? Nature 312:566-570.
58. Oshima M, Koizumi S, Fujita K, Guroff G (1989): Nerve growth factor-induced decrease in the calpain activity of PC12 cells. J Biol Chem 264:20811-20816.
59. Pahlman SR, Ruusala A-I, Abrahamsson L, Mattsson MEK, Esscher T (1984): Retinoic acid induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Diff 14:135-144.
60. Pinter M, Friedrich P (1988): The calcium-dependent proteolytic system calpain-calpastatin in drosophila melanogaster. Biochem J 253:467-473.
61. Pontremoli S, Salamino F, Sparatore B, De Tullio R, Pontremoli R, Melloni E (1988): Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. Biochem Biophys Res Commun 157:867-874.
62. Saido TC, Yokota M, Nagao S, Yamaura I, Tani E, Tsuchiya T, Suzuki K, Kawashima S (1993): Spatial resolution of fodrin proteolysis in postischemic brain. J Biochem (Tokyo) 113:591-599.
63. Saido TC, Nagao S, Shiramine M, Tsukaguchi M, Yoshizawa T, Soriumachi H, Ito H, Tsuchiya T, Kawashima S, Suzuki K (1994): Distinct kinetics of subunit autolysis in mammalian m-calpain activation. FEBS Lett 346:263-267.
64. Saito K, Elce JS, Hamos JE, Nixon RA (1993): Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90:2628-2632.
65. Saito Y, Kawashima S (1989): The neurite initiating effect of a tripeptide aldehyde protease inhibitor on PC12h cells. J Biochem 106:1035-1040.
66. Saito Y, Tsubuki S, Ito H, Kawashima S (1990): The structure-function relationship between peptide aldehyde derivatives on initiation of neurite outgrowth in PC12h cells. Neurosci Lett 120:1-4.
67. Saito Y, Saido TC, Sano K, Kawashima S (1994): The calpain-calpastatin system is regulated differently during human neuroblastoma cell differentiation to Schwannian and neuronal cells. FEBS Lett 353:327-331.
68. Sargianos N, Gaitanaki C, Beis I (1995): Studies on the auotolysis of m-calpain from the skeletal muscle of the amphibian Rana ridibunda. J Exp Zool 271:82-94.
69. Schlaepfer WW, Lee C, Trojanowski JQ, Lee VM (1984): Persistence of immunoreactive neurofilament protein breakdown products in transected rat sciatic nerve. J Neurochem 43:857-864.
70. Schlaepfer WW, Lee C, Lee VM, Zimmerman UJ (1985): An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis. J Neurochem 44:502-509.
71. Schollmeyer JE (1988): Calpain II involvement in mitosis. Science 240:911-913.
72. Shea TB, Beerman ML, Griffin WR, Leli U (1994): Degradation of protein kinase Cα and its free catalytic subunit, protein kinase M, in intact human neuroblastoma cells and under cell-free conditions: evidence that PKM is degraded by calpain-mediated proteolysis at a faster rate than PKC. FEBS Lett 350:223-229.
73. Shea TB, Cressman CM, Spencer MJ, Beermann ML, Nixon RA (1995): Enhancement of neurite outgrowth following calpain inhibition is mediated by proteinase kinace C. J Neurochem 65:517-527.
74. Siddiqui AA, Zhou Y, Podesta RB, Karcz SR, Tognon CE, Strejan GH, Dekaban GA, Clarke MW (1993): Characterization of Ca+2-dependent neutral protease (calpain) from human blood flukes, Schistosoma Mamsoni. Biochim Biophys Acta 1181:37-44.
75. Siman R, Baudry M, Lynch G (1984): Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease. Proc Natl Acad Sci USA 81:3572-3576.
76. Siman R, Baudry M, Lynch G (1985): Regulation of glutamate receptor binding by the cytoskeletal protein fodrin. Nature 313: 225-228.
77. Siman R, Card JP, Nelson RB, Davis LG (1989a) Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 3:275-285.
78. Siman R, Noszek JC, Kegerise C (1989b): Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 9:1579-1590.
79. Siman R (1990): Role of calpain I in excitatory amino acid-induced degenerative structural changes. In Guidotti A (ed): "Neurotoxicity of Excitatiry Amino Acids." New York: Raven Press, pp 145-161.
80. Song DK, Malmstrom T, Kater SB, Mykles DL (1994): Calpain inhibitors block Ca (+2)-induced suppression of neurite outgrowth in isolated hippocampal pyramidal neurons. J Neurosci 39:474-481.
81. Sorimachi H, Saido TC, Suzuki K (1994): New era of calpain research. Discovery of tissue specific calpains. FEBS Lett 343:1-5.
82. Suzuki K, Imajoh S, Emori Y, Kawashima H, Minami Y, Ohno S (1987): Calcium activated neutral protease and its endogenous inhibitor. FEBS Lett 220:271-277.
83. Swanson GJ, Vrbova G (1987): Effects of low calcium and inhibition of calcium-activated neutral protease (CANP) on mature nerve terminal structure in the rat sternocostalis muscle. Brain Res 430:199-203.
84. Takano E, Yumoto N, Kannagi R, Murachi T (1984): Molecular diversity of calpastatin in mammalian organs. Biochem Biophys Res Commun 122:912-917.
85. Takeuchi KH, Saito KI, Nixon RA (1992): Immunoassay and activity of calcium-activated neutral proteinase (mCANP): distribution in soluble and membrane-associated fractions in human and mouse brain. J Neurochem 58:1526-1532.
86. Vitto A, Nixon RA (1986): Calcium-activated neutral proteinase of human brain: subunit structure and enzymatic properties of multiple molecular forms. J Neurochem 47:1039-1051.
87. Yoshimura N, Tsukahara I, Murachi T (1984): Calpain and calpastatin in porcine retina. Identification and action on microtubule-associated proteins. Biochem J 223:47-51.